Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Urinary Bladder Neoplasms × Lapatinib × Clear all

Phase

Phase 2 3 Phase 1 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Oesophagogastric Cancer 1 Inflammatory Breast Neoplasms 1 Carcinoma, Ductal, Breast 1 Breast Diseases 1

Interventions

Gemcitabine 6 Carboplatin 4 Cisplatin 3 valrubicin 2 vinflunine 1 pertuzumab 1 pembrolizumab 1 cabazitaxel 1 avelumab 1 apaziquone 1 XRP6258 1 Watchful Waiting 1 Vinblastine 1 Trastuzumab 1 Transurethral Resection of Bladder 1 Tranexamic Acid 1 Saline Solution 1 Oncolytic Virotherapy 1 Mitomycin 1 Methotrexate 1 Magnetic Resonance Spectroscopy 1 Lapatinib 1 Interferons 1 Interferon-alpha 1 Gabapentin 1 Circulating Tumor DNA 1 Celecoxib 1 BCG Vaccine 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00949455 2015-04-15

LaMB

Queen Mary University of London

Phase 2/3 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡